Ceramide stimulates ABCA12 expression via peroxisome proliferator-activated receptor {delta} in human keratinocytes.
ABCA12 (ATP binding cassette transporter, family 12) is a cellular membrane transporter that facilitates the delivery of glucosylceramides to epidermal lamellar bodies in keratinocytes, a process that is critical for permeability barrier formation. Following secretion of lamellar bodies into the stratum corneum, glucosylceramides are metabolized to ceramides, which comprise approximately 50% of the lipid in stratum corneum. Gene mutations of ABCA12 underlie harlequin ichthyosis, a devastating skin disorder characterized by abnormal lamellar bodies and a severe barrier abnormality. Recently we reported that peroxisome proliferator-activated receptor (PPAR) and liver X receptor activators increase ABCA12 expression in human keratinocytes. Here we demonstrate that ceramide (C(2)-Cer and C(6)-Cer), but not C(8)-glucosylceramides, sphingosine, or ceramide 1-phosphate, increases ABCA12 mRNA expression in a dose- and time-dependent manner. Inhibitors of glucosylceramide synthase, sphingomyelin synthase, and ceramidase and small interfering RNA knockdown of human alkaline ceramidase, which all increase endogenous ceramide levels, also increased ABCA12 mRNA levels. Moreover, simultaneous treatment with C(6)-Cer and each of these same inhibitors additively increased ABCA12 expression, indicating that ceramide is an important inducer of ABCA12 expression and that the conversion of ceramide to other sphingolipids or metabolites is not required. Finally, both exogenous and endogenous ceramides preferentially stimulate PPARdelta expression (but not other PPARs or liver X receptors), whereas PPARdelta knockdown by siRNA transfection specifically diminished the ceramide-induced increase in ABCA12 mRNA levels, indicating that PPARdelta is a mediator of the ceramide effect. Together, these results show that ceramide, an important lipid component of epidermis, up-regulates ABCA12 expression via the PPARdelta-mediated signaling pathway, providing a substrate-driven, feed-forward mechanism for regulating this key lipid transporter.
Jiang
Yan J
YJ
Metabolism Section, Veterans Affairs Medical Center, Northern California Institute for Research and Education, University of California, San Francisco, California 94121, USA. yan.jiang@med.va.gov
Uchida
Yoshikazu
Y
Lu
Biao
B
Kim
Peggy
P
Mao
Cungui
C
Akiyama
Masashi
M
Elias
Peter M
PM
Holleran
Walter M
WM
Grunfeld
Carl
C
Feingold
Kenneth R
KR
D018528:ATP-Binding Cassette Transporters / Q000378:metabolism*; D001692:Biological Transport; D002478:Cells, Cultured; D002518:Ceramides / Q000737:chemistry* / Q000378:metabolism; D005786:Gene Expression Regulation; D005964:Glucosyltransferases / Q000037:antagonists & inhibitors; D006801:Humans; D015603:Keratinocytes / Q000166:cytology / Q000378:metabolism*; D008055:Lipids / Q000737:chemistry; D008954:Models, Biological; D047494:PPAR delta / Q000378:metabolism*; D012333:RNA, Messenger / Q000378:metabolism; D034741:RNA, Small Interfering / Q000378:metabolism; D015398:Signal Transduction; D013997:Time Factors
C473801:ABCA12 protein, human; D018528:ATP-Binding Cassette Transporters; D002518:Ceramides; D008055:Lipids; D047494:PPAR delta; D012333:RNA, Messenger; D034741:RNA, Small Interfering; D005964:Glucosyltransferases